Literature DB >> 8843880

Low blood pressure in Down's syndrome, A link with Alzheimer's disease?

R A Morrison1, A McGrath, G Davidson, J J Brown, G D Murray, A F Lever.   

Abstract

Low blood pressure is reported in Down's syndrome (DS). To assess this and determine whether low pressure results from the disease or from long-term residence in hospital, we measured blood pressure with a random-zero sphygmomanometer in three groups of patients: 52 DS inpatients, 62 DS outpatients, and 60 outpatients with other forms of mental handicap. Relative to normal reference populations, blood pressure was low in both DS inpatients (systolic, score -33 mm Hg, P < .0001) and DS outpatients (-25 mm Hg, P < .0001). It was normal in non-DS outpatients (-4.0 mm Hg, P = .3). Blood pressure rose normally with age in the non-DS group but not in the DS group. We conclude that blood pressure is low in DS and that this is a feature of the disease rather than of the protected environment in which patients live. A mechanism related to trisomy 21 is likely, and there may be a link with Alzheimer's disease (AD) because blood pressure is also low in Alzheimer's and a high proportion of Ds patients develop this disease. If, as is likely, blood pressure is lowered in Alzheimer's by the neuropathy, the same neuropathy developing early in DS may also reduce blood pressure.

Entities:  

Mesh:

Year:  1996        PMID: 8843880     DOI: 10.1161/01.hyp.28.4.569

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

1.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

Review 2.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

Review 3.  Functional genetic variation of human miRNAs and phenotypic consequences.

Authors:  Christelle Borel; Stylianos E Antonarakis
Journal:  Mamm Genome       Date:  2008-09-12       Impact factor: 2.957

4.  Cross-Sectional Study of Arterial Stiffness in Adolescents with Down Syndrome.

Authors:  Andrea Kelly; Sheela N Magge; Rachel Walega; Claire Cochrane; Mary E Pipan; Babette S Zemel; Meryl S Cohen; Samuel S Gidding; Ray Townsend
Journal:  J Pediatr       Date:  2019-06-11       Impact factor: 4.406

5.  Hypertension in Adults With Intellectual Disability: Prevalence and Risk Factors.

Authors:  Elizabeth C Schroeder; Lindsay DuBois; Molly Sadowsky; Thessa I M Hilgenkamp
Journal:  Am J Prev Med       Date:  2020-02-12       Impact factor: 5.043

Review 6.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

7.  Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes.

Authors:  Praveen Sethupathy; Christelle Borel; Maryline Gagnebin; Gregory R Grant; Samuel Deutsch; Terry S Elton; Artemis G Hatzigeorgiou; Stylianos E Antonarakis
Journal:  Am J Hum Genet       Date:  2007-07-12       Impact factor: 11.025

8.  Alzheimer's Disease in Down Syndrome.

Authors:  Elizabeth Head; David Powell; Brian T Gold; Frederick A Schmitt
Journal:  Eur J Neurodegener Dis       Date:  2012-12

9.  Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life.

Authors:  Daishi Hirano; Saori Miwa; Daisuke Kakegawa; Chisato Umeda; Yoichi Takemasa; Ai Tokunaga; Kawakami Yuhei; Akira Ito
Journal:  Pediatr Nephrol       Date:  2021-01-19       Impact factor: 3.714

10.  Stiffness of the large arteries in individuals with and without Down syndrome.

Authors:  Anabel N Rodrigues; Luan Cesar Coelho; Washington L S Goncalves; Sonia Alves Gouvea; Maria José Rossi Vasconcellos; Roberto S Cunha; Glaucia R Abreu
Journal:  Vasc Health Risk Manag       Date:  2011-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.